PanGen Biotech Inc. (KOSDAQ:A222110) agreed to acquire PANACEA Inc. from Invites Ventures Co., Ltd., and others on June 21, 2024. The consideration consists of 7.06 million common equity of PanGen Biotech Inc. to be issued for common equity of PANACEA Inc.

The expected completion of the transaction is September 5, 2024.